Home Cart 0 Sign in  
X

[ CAS No. 4010-81-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4010-81-5
Chemical Structure| 4010-81-5
Chemical Structure| 4010-81-5
Structure of 4010-81-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4010-81-5 ]

Related Doc. of [ 4010-81-5 ]

Alternatived Products of [ 4010-81-5 ]

Product Details of [ 4010-81-5 ]

CAS No. :4010-81-5 MDL No. :MFCD17430374
Formula : C9H10ClN5O Boiling Point : -
Linear Structure Formula :- InChI Key :SADWLAUYKSMNMQ-UHFFFAOYSA-N
M.W : 239.66 Pubchem ID :3274603
Synonyms :

Calculated chemistry of [ 4010-81-5 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.44
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 62.42
TPSA : 66.93 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.95 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.61
Log Po/w (XLOGP3) : 1.15
Log Po/w (WLOGP) : 0.46
Log Po/w (MLOGP) : -0.09
Log Po/w (SILICOS-IT) : 1.57
Consensus Log Po/w : 0.94

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.4
Solubility : 0.953 mg/ml ; 0.00398 mol/l
Class : Soluble
Log S (Ali) : -2.15
Solubility : 1.7 mg/ml ; 0.00708 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.98
Solubility : 0.254 mg/ml ; 0.00106 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.31

Safety of [ 4010-81-5 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 4010-81-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 4010-81-5 ]

[ 4010-81-5 ] Synthesis Path-Downstream   1~88

  • 2
  • [ 110-91-8 ]
  • [ 5451-40-1 ]
  • [ 4010-81-5 ]
YieldReaction ConditionsOperation in experiment
99% In water; at 100℃; for 0.25h;Heating / reflux; Reference Example 202-Chloro-6-morpholin-4-yl-9J-purineTo a solution of 2,6-dichloro-9H-purine (5.0 g, 26.46 mmol) in water (100 mL) was added morpholine (6.9 mL, 79.37 mmol). The resulting mixture was heated at reflux for 15 min, and then allowed to cool to RT. The resultant white precipitate was collected by filtration and washed with water, MeOH and EtOH, then dried at 40 C for 18 h to give the title compound (6.26 g, 99 %).1H NMR (400 MHz, DMSOd6): δ 3.72 (m, 4 H), 4.18 (m, 4 H), 8.16 (s, 1 H) and 13.24 (bs, 1 H).
99% With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 1h; a) 2-Chloro-6-morpholin-4-yl-9H-purineTo a solution of 2,6-dichloro-9H-purine (1.2 g, 6.35 mmol) in /V,/V-dimethylformamide (5 mL) was added morpholine (553 mg, 6.35 mmol) followed by diisopropylethyl amine (1 .2 mL, 6.87 mmol), dropwise via a syringe. The solution was stirred at room temperature for 1 hour until precipitate formed. The reaction mixture was then poured into water and the precipitate was filtered. Upon drying under high vacuum, 2-chloro-6-morpholin-4-yl-9H-purine was isolated as an off-white solid. (1.5 g, 99%) LC/MS analysis method 7, mass (ES+) m/z 240.2 1H NMR (DMSO-d6): 13.21 (1 H, brs), 8.15 (1 H, s), 4.18 (4H, brs), 3.72 (4H, t)
97% In ethanol; at 30℃; for 3h; Into a 500ml reactor, put 2,6-dichloropurine (5.00g, 0.0265mol), absolute ethanol (100ml), and then slowly add morpholine (3.69g, 0.042mol) dropwise. After feeding, react at 30C for 3h. Filter and wash the filter cake with (3×30 ml) ethanol. The filter cake was collected and dried under vacuum at 40C for 30 minutes to obtain 4-(2-chloro-9H-purin-6-yl)morpholine (6.37 g, 97%).
96% In water; for 0.25h;Heating / reflux; Example 66 Preparation of N2-[2-(3,4-Dimethoxy-phenyl)-ethyl]-6-morpholin-4-yl-N8-p-tolyl-9H-purine-2,8-diamine The title compound was synthesised by the method shown in Scheme 3 As shown in Scheme 3 above, a mixture of 2,6-dichloropurine (1.90 g, 10 mmol) and morpholine (2.34 g, 30 mmol) in water (25 mL) was heated under reflux for 15 min. Solidified reaction mixture was cooled to room temperature. Solid was filtered out and washed with water, methanol and ether. The 2-chloro-6-morpholin-4-yl-9H-purine was obtained in 96% yield (2.30 g).
95% In ethanol; at 20℃; for 3h; At room temperature 2,6-dichloropurine(10 g, 0.05 mol) was added to ethanol (120 ml), and after lyophilization, morpholine (6.91 g, 0.08 mol) was added dropwise to the reaction mixture, and stirred at room temperature for about 3 h. After the reaction was stopped, it was filtered, and the filter cake was washed three times with diethyl ether to give a pale yellow powder (12.02 g, yield 95%).
90% In tetrahydrofuran; at 20℃; for 16h; Step 1: Synthesis of 4-(2-chloro-9H-purin-6-yl)morpholine (13a)Morpholine (1.39 mL, 15.87 mmol) was added to a solution of la (1.0 g, 5.29 mmol) in THF (26 mL). The resulting mixture was stirred at room temperature for 16 h. White precipitate was observed immediately upon addition of morpholine. The white precipitate was filtered off and washed with water (x2) and methanol (x2) to afford 13a (1.13 g, 90%).
90% at 0 - 22℃; for 2h; Put 2,6-dichloropurine (18.900g, 100mmol) in a three-necked flask, add MeOH (500mL), cool the reaction solution to 0-5C, add morpholine (150mmol) dropwise, and increase the temperature to 20- Reacted at 22 for 2h, filtered with suction, the filter cake was washed with water (50mL) and methanol (30mL) successively, and then dried under vacuum at 45 to obtain the product 4-(2-chloro-9H-purin-6-yl)morpholine (21.384g ), the yield is 90%.
84% With triethylamine; In ethanol; at 20℃; for 6h; General procedure: To an oven dried round-bottomed flask (25 mL) containing EtOH(10 mL) was added compound 5 (1 mmol), respective secondaryamines (1.2 mmol) and triethyl amine (1.5 mmol). The reactionmixture was then allowed to stirred for 6 h at room temperature.The progress of the reaction was monitored by TLC. After completionof the reaction organic solvent was evaporated under reducedpressure, water (50 mL) was added to the reaction mixture andextracted with EtOAc (2 x 25 mL). Organic layer was then collected,washed with water (2 x 100 mL) and brine, dried over Na2SO4 andfinally excess of solvent was evaporated under vacuum. The cruderesidue thus obtained was purfied column using MeOH/CHCl3 aseluent to afford compounds 6a-j.
80.8% With triethylamine; In ethanol; for 10h;Reflux; General procedure: A suspension of 300 mg of 2,6-dichloro-9H-purine (1), 2,4-dichlorothieno[3,2-d]pyrimidine (6) or 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine (9) in 10mL of EtOH was added morpholine or 4-aminotetrahydropyran (1.2 equiv) and 300 mL of triethylamine. The mixtrue was refluxed for 10 h. After the disappearance of compounds 1, 6 or 9 detected by TLC, the solution was evaporated in vacuum to yield a syrup. Then, it was neutralized by concentrated ammonium hydroxide. After filtering off, the residue was washed with cold water and cold acetone successively to remove the triethylammonium hydrochloride.
80% With N-ethyl-N,N-diisopropylamine; In 2-methyl-propan-1-ol; at 75℃; for 16h; A solution of 2,6-dichloro-9H-purine (5g, 26mmol), morpholine (2g, 26mmol) and N,N- diisopropylethylamine (6.7g, 52mmol) in isopropanol (200 mL) was stirred at 75 C for 16h. The mixture was filtered to obtain 4-(2-chloro-9H-purin-6-yl)morpholine (5g, 80%) as white solid. 1H NMR (400 MHz, DMSO-de) d 13.24 (s, 1 H), 8.16 (s, 1 H), 4.19 (s, 4H), 3.83 - 3.59 (m, 4H).
80% With N-ethyl-N,N-diisopropylamine; In 2-methyl-propan-1-ol; at 75℃; for 16h; A solution of 2,6-dichloro-9H-purine (5g, 26mmol), morpholine (2g, 26mmol) and N,N- diisopropylethylamine (6.7g, 52mmol) in isopropanol (200 mL) was stirred at 75 C for 16h. The mixture was filtered to obtain 4-(2-chloro-9H-purin-6-yl)morpholine (5g, 80%) as white solid. 1H NMR (400 MHz, DMSO-de) d 13.24 (s, 1 H), 8.16 (s, 1 H), 4.19 (s, 4H), 3.83 - 3.59 (m, 4H).
80% With N-ethyl-N,N-diisopropylamine; In 2-methyl-propan-1-ol; at 75℃; for 16h; A solution of 2,6-dichloro-9H-purine (5g, 26mmol), morpholine (2g, 26mmol) and N,N- diisopropylethylamine (6.7g, 52mmol) in isopropanol (200 mL) was stirred at 75 C for 16h. The mixture was filtered to obtain 4-(2-chloro-9H-purin-6-yl)morpholine (5g, 80%) as white solid. 1H NMR (400 MHz, DMSO-de) d 13.24 (s, 1 H), 8.16 (s, 1 H), 4.19 (s, 4H), 3.83 - 3.59 (m, 4H).
In ethanol; 2,6-dichloropurine (approximately 0.20 g, 1.1 mmol) was taken up in ethanol (50 mL) and treated with morpholine (2 mL). The white precipitate was collected by filtration, washed with ethanol, and dried under house vacuum to provide 4-(2-chloro-9H-purin-6-yl)morpholine. MS (ES+): 240.0, 242.0 (M+H)+
In ethanol; at 20℃; for 2.5h;Reflux; Morpholine (46.9 ml, 538.2 mmol) was added to an ethanol solution (1.2 l) of 2,6-dichloropurine (50.9 g, 269.1 mmol) at room temperature and the resulting mixture was stirred and heated to reflux for 2.5 hours. The reaction mixture was left standing to cool and then concentrated until the solvent was reduced nearly by half in volume and the solid was collected by filtration. The solid was washed with ethanol and dried at 50 C. under reduced pressure to give a mixture (63.3 g, 95%) of the title compound and morpholine hydrochloride (approx. 13:1) as a white solid.1H-NMR (DMSO-d6) δ: 3.67-3.77 (4H, m), 3.84-4.56 (4H, brm), 8.16 (1H, s).
With N-ethyl-N,N-diisopropylamine; In butan-1-ol; at 80℃; for 2h; To a n-butanol containing round bottom flask, 2,6-dichloropurine (1) (50 mmol), N,N-diisopropylethylamine (DIPEA) (10 mmol) and morpholine (2) (50 mmol) were added and was refluxed at 80 C for 2 h to generate a reactive intermediate (3). Thin layer chromatography [hexane(7):ethyl acetate(3)] was utilized to identify the complete formation of product. After 12 h stirring at room temperature, it was poured intoice-cold water and stirred for 1 h to isolate free material in powder form. The separated product was filtered and washed with cold water. The isolated product was dried for next 12 h at room temperature.For the purification purpose, hexane stripping was performed using roteva evaporator at 60 C and 500 mm pressure through 100 rpm speed. The step-I crude product was characterized by 1H NMR and IR techniques to carry out further reactions
In butan-1-ol; at 70℃; for 1h;Microwave irradiation; General procedure: 15 mL n-BuOH, 2,6-dichloro-9H-purine 1 (1.0 equiv.)and relative amines 2 (3.0 equiv.) were added in a microwave reactiontube. The vessel was heated to 70 C for 1 h. The reaction was cooled to room temperature, the suspension was filtered andwashed with methanol to afford the compound 3 as a yellow solid.

Reference: [1]Patent: WO2009/53716,2009,A1 .Location in patent: Page/Page column 46; 65
[2]Patent: WO2012/104776,2012,A1 .Location in patent: Page/Page column 57
[3]Patent: CN111875606,2020,A .Location in patent: Paragraph 0035-0040; 0043-0044
[4]Patent: US2008/58297,2008,A1 .Location in patent: Page/Page column 42
[5]Patent: CN108794478,2018,A .Location in patent: Paragraph 0097; 0099; 0100
[6]Patent: WO2015/137887,2015,A1 .Location in patent: Page/Page column 67
[7]Journal of Medicinal Chemistry,2018,vol. 61,p. 1552 - 1575
[8]Patent: CN112920199,2021,A .Location in patent: Paragraph 0153; 0565; 0568-0571
[9]Tetrahedron Letters,1998,vol. 39,p. 1827 - 1830
[10]European Journal of Medicinal Chemistry,2017,vol. 126,p. 675 - 686
[11]European Journal of Medicinal Chemistry,2018,vol. 151,p. 836 - 848
[12]Patent: WO2021/247841,2021,A1 .Location in patent: Page/Page column 65-66
[13]Patent: WO2021/247841,2021,A1 .Location in patent: Page/Page column 65-66
[14]Patent: WO2021/247841,2021,A1 .Location in patent: Page/Page column 65-66
[15]Patent: US2008/233127,2008,A1 .Location in patent: Page/Page column 37
[16]Bioorganic and Medicinal Chemistry Letters,2010,vol. 20,p. 636 - 639
[17]Patent: US2010/130492,2010,A1 .Location in patent: Page/Page column 67-68
[18]Bioorganic and Medicinal Chemistry Letters,2010,vol. 20,p. 653 - 656
[19]Bioorganic and Medicinal Chemistry Letters,2012,vol. 22,p. 4377 - 4385
[20]Asian Journal of Chemistry,2019,vol. 31,p. 2871 - 2874
[21]European Journal of Medicinal Chemistry,2020,vol. 198
  • 4
  • [ 4010-81-5 ]
  • 9-Benzyl-2,6-di-morpholin-4-yl-9H-purine [ No CAS ]
  • 5
  • [ 4010-81-5 ]
  • 9-(2,3-Difluoro-benzyl)-2,6-di-morpholin-4-yl-9H-purine [ No CAS ]
  • 6
  • [ 110-91-8 ]
  • [ 5451-40-1 ]
  • [ 4010-81-5 ]
YieldReaction ConditionsOperation in experiment
96% In water; for 0.25h;Heating / reflux; As shown in Scheme 3 above, a mixture of 2,6-dichloropurine (1.90 g, 10 mmol) and morpholine (2.34 g, 30 mmol) in water (25 mL) was heated under reflux for 15 min. Solidified reaction mixture was cooled to room temperature. Solid was filtered out and washed with water, methanol and ether. The 2-chloro-6-morpholin-4-yl-9H-purine was obtained in 96% yield (2.30 g). A mixture of 2-chloro-6-morpholin-4-yl-9H-purine (1.92 g, 8 mmol) and 2-(3,4-dimethoxyphenyl)ethylamine (4.35 g, 24 mmol) in sealed tube and under nitrogen was stirred at 190-195 C. for 1 hour. The reaction mixture turned to clear solution initially and then formed a slurry. The reaction mixture was cooled to room temperature diluted with methanol (8 mL) and the solid was collected by filtration, washed with methanol and Et2O and dried to afford 2.30 g (74% yield) of [2-(3,4-dimethoxy-phenyl)-ethyl]-(6-morpholin-4-yl-9H-purin-2-yl)amine. [0059] 1H NMR (DMSO-d6) δ (ppm), 12.22 (bs, 1H), 7.69 (d, J=9.0 Hz, 1H), 6.86-6.73 (m, 3H), 6.30-6.22 (m, 1H), 4.12 (bs, 4H), 3.74-3.69 (m, 10H), 3.43 (t, J=6.0 Hz, 2H), 2.78-2.73 (m, 2H). [0060] ESMS calcd for C19H24N6O3: 384.19; Found: 385.2 (M+H)+.
In ethanol; at 20℃; for 12h; To a solution of the 2,6-dichloropurine (0.8 g, 4.23 mmol) dissolved in EtOH (40 mL) in is added morpholine (1.5 eq). The reaction is stirred for 12 hr at room temperature and the crude solid product filtered off. The crude product is washed with Et2O and dried in vacuo affording 0.75 g of a beige solid.To the morpholine product of Step 1 (50 mg, 0.21 mmol) dissolved in DMF (0.5 mL) is added the desired aryl boronic acid (1.5 eq), Na2CO3 solution (2 eq), and Pd(PPh3)4 (catalytic amount) to a microwave conical vial. The reaction is heated under MW irradiation at 175 C. for 10 minutes. The crude reaction is then concentrated and purified via preparative HPLC using a Gilson instrument (see below).
  • 7
  • [ 4010-81-5 ]
  • [ 120-20-7 ]
  • [ 682337-90-2 ]
YieldReaction ConditionsOperation in experiment
74% at 190 - 195℃; for 1h; As shown in Scheme 3 above, a mixture of 2,6-dichloropurine (1.90 g, 10 mmol) and morpholine (2.34 g, 30 mmol) in water (25 mL) was heated under reflux for 15 min. Solidified reaction mixture was cooled to room temperature. Solid was filtered out and washed with water, methanol and ether. The 2-chloro-6-morpholin-4-yl-9H-purine was obtained in 96% yield (2.30 g). A mixture of 2-chloro-6-morpholin-4-yl-9H-purine (1.92 g, 8 mmol) and 2-(3,4-dimethoxyphenyl)ethylamine (4.35 g, 24 mmol) in sealed tube and under nitrogen was stirred at 190-195 C. for 1 hour. The reaction mixture turned to clear solution initially and then formed a slurry. The reaction mixture was cooled to room temperature diluted with methanol (8 mL) and the solid was collected by filtration, washed with methanol and Et2O and dried to afford 2.30 g (74% yield) of [2-(3,4-dimethoxy-phenyl)-ethyl]-(6-morpholin-4-yl-9H-purin-2-yl)amine. [0059] 1H NMR (DMSO-d6) δ (ppm), 12.22 (bs, 1H), 7.69 (d, J=9.0 Hz, 1H), 6.86-6.73 (m, 3H), 6.30-6.22 (m, 1H), 4.12 (bs, 4H), 3.74-3.69 (m, 10H), 3.43 (t, J=6.0 Hz, 2H), 2.78-2.73 (m, 2H). [0060] ESMS calcd for C19H24N6O3: 384.19; Found: 385.2 (M+H)+.
at 190 - 195℃; for 1h; A mixture of 2-chloro-6-morpholin-4-yl-9H-purine (1.92 g, 8 mmol) and 2-(3,4-dimethoxyphenyl)ethylamine (4.35 g, 24 mmol) in sealed tube and under nitrogen was stirred at 190-195 C. for 1 hour. The reaction mixture turned to clear solution initially and then formed a slurry. The reaction mixture was cooled to room temperature diluted with methanol (8 mL) and the solid was collected by filtration, washed with methanol and Et2p and dried to afford 2.30 g (740% yield) of [2-(3,4-dimethoxy-phenyl)-ethyl]-(6-morpholin-4-yl-9H-purin-2-yl)amine. 1H NMR (DMSO-d6) δ (ppm), 12.22 (bs, 1H), 7.69 (d, J=9.0 Hz, 1H), 6.86-6.73 (m, 3H), 6.30-6.22 (m, 1H), 4.12 (bs, 4H), 3.74-3.69 (m, 10H), 3.43 (t, J=6.0 Hz, 2H), 2.78-2.73 (m, 2H). ESMS calcd for C19H24N6O3: 384.19; Found: 385.2 (M+H)+.
  • 8
  • [ 3040-44-6 ]
  • [ 4010-81-5 ]
  • [ 1062205-50-8 ]
YieldReaction ConditionsOperation in experiment
45% With tributylphosphine; diethylazodicarboxylate; In tetrahydrofuran; To 2-chloro-6-morpholinoylpurine (500 mg, 2.09 mmol) 1-hydroxyethylpiperidine (405 mg, 3.13 mmol) and PBu3 (821 mg, 3.13 mmol) dissolved in THF (2 mL) was added DEAD (545 mg, 3.13 mmol). The mixture is stirred over night, and the crude product purified via silica gel chromatography (10% MeOH/EtOAc) to afford 330 mg (45% yield) of a yellow solid.
  • 9
  • [ 4010-81-5 ]
  • [ 4727-72-4 ]
  • [ 1062205-49-5 ]
YieldReaction ConditionsOperation in experiment
To the desired 1-Benzyl-4-hydroxypiperidine (1.14 g, 5.97 mmol) and PPh3 (1.6 g, 5.96 mmol) dissolved in THF (20 mL) is added DEAD (0.94 mL, 5.97 mmol). The mixture is stirred for 30 min. and the 2-chloro-6-morpholino purine (obtained from the step 1), (0.95 g, 3.98 mmol) in THF (10 mL) is added. The reaction is stirred for 72 hr, concentrated, and purified via silica gel chromatography (10% MeOH/EtOAc) affording a yellow solid.
  • 10
  • [ 4010-81-5 ]
  • [ 87199-18-6 ]
  • [ 934545-07-0 ]
YieldReaction ConditionsOperation in experiment
With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,2-dimethoxyethane; water; at 180℃; for 1h; A mixture of <strong>[4010-81-5]4-(2-chloro-9H-purin-6-yl)morpholine</strong> (0.18 g, 0.75 mmol), tetrakis(triphenylphosphine)palladium (30 mg), and 3-hydroxyphenylboronic acid (0.16 g, 1.1 mmol) in 1,2-dimethoxyethane (2.6 mL) and 2 M aqueous sodium carbonate (0.75 mL) was heated in a microwave reactor for one hour at 180 C. After being allowed to cool to room temperature, the mixture was acidified with 5% aqueous potassium hydrogen sulfate solution and then extracted with ethyl acetate. Organics were washed successively with water and saturated aqueous sodium hydrogen carbonate solution, then dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to afford a crude white solid. The crude material was purified by reverse phase HPLC, employing a gradient elution of 85% A solvent (0.1% aqueous trifluoroacetic acid) to 100% B solvent (acetonitrile) to afford 3-(6-morpholino-9H-purin-2-yl)phenol as a white powder (80 mg). MS (ES+): 298.0 (M+H)+
  • 11
  • [ 4010-81-5 ]
  • [ 445264-60-8 ]
  • [ 1062204-59-4 ]
YieldReaction ConditionsOperation in experiment
48% With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,2-dimethoxyethane; water; at 175℃; for 0.166667h; To a microwave processing tube is charged dimethoxyethane (10 mL), 2M aqueous Na2CO3 solution (4.04 mL, 8.08 mmol, 2 eq), (Ph3P)4Pd (233 mg, 0.2 mmol, 0.05 eq), <strong>[445264-60-8]3-methoxy-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine</strong> (1140 mg, 4.85 mmol, 1.2 eq) and 2-chloro-6-morpholin-4-yl-9H-purine (968 mg, 4.04 mmol, 1 eq), and the vessel sealed. The mixture is heated to 175 C. for 10 minutes, afterwards, the mixture is evaporated to dryness. MeOH (20 mL) and silica-gel (g) are added and the solvent is removed in vacuo to form a silica-gel plug. The mixture is purified by chromatography with a mixture of CH2Cl2/MeOH/NH3 20:1:0.1 as eluent giving the product as off white solid (600 mg, 48% yield; MS (ESI) m/z=312.2).
  • 12
  • 2-(2-bromoethoxy)tetrahydropyran [ No CAS ]
  • [ 4010-81-5 ]
  • [ 1148003-91-1 ]
YieldReaction ConditionsOperation in experiment
82% With potassium carbonate; In N,N-dimethyl-formamide; at 50℃; for 7h; Reference Example 842-Chloro-6-morpholin-4-yl-9-[2-(tetrahydro-pyraii-2-yloxy)-ethyl]-9J-purineTo a solution of 2-chloro-6-morpholin-4-yl-9H-purine (1.00 g, 4.17 mmol) in DMF (30 mL) were added 2-(2-bromo-ethoxy)-tetrahydro-pyran (1.26 mL, 8.34 mmol) and potassium carbonate (1.73 g, 12.52 mmol). The reaction mixture was heated at 50 C for 7 h, then allowed to cool to RT and quenched with water (60 mL). The resultant white precipitate was collected by filtration and washed with water and diethyl ether, then dried under vacuum to give the title compound (1.26 g, 82 %). [M + H]+ 368.4
  • 13
  • [ 4010-81-5 ]
  • [ 74-96-4 ]
  • [ 932045-32-4 ]
YieldReaction ConditionsOperation in experiment
80% With sodium hydroxide; In N,N-dimethyl-formamide; at 150℃; for 2h;Product distribution / selectivity; Reference Example 212-ChIoro-9-ethyl-6-morpholin-4-yl-9/-r-purine To a solution of 2-chloro-6-morpholin-4-yl-9H-purine (304 mg, 1.27 mmol) in DMF(6 mL) were added bromoethane (284 μL, 3.81 mmol) and sodium hydroxide (152 mg, 3.81 mmol). The reaction mixture was heated at 150 C for 2 h, then allowed to cool to RT. The reaction mixture was partitioned between water and DCM, the layers separated and the aqueous layer was further extracted with DCM. The combined organic fractions were washed with water, dried (Na2SO4) and concentrated in vacuo to give the title compound as a yellow solid (210 mg, 80 %). <n="67"/>1H NMR (400 MHz, CDCl3): δ 1.50 (t, J = 7.3 Hz, 3 H), 3.79-3.85 (m, 4 H), 4.13-4.32 (m, 6 H) and 7.71 (s, 1 H).
  • 14
  • [ 4010-81-5 ]
  • [ 7051-34-5 ]
  • [ 1222105-32-9 ]
YieldReaction ConditionsOperation in experiment
90% With potassium carbonate; In N,N-dimethyl-formamide; at 20 - 80℃; for 3h;Inert atmosphere; Potassium carbonate (36.0 g, 260.5 mmol) and cyclopropylmethyl bromide (20.2 g, 143.3 mmol) were added to an N,N-dimethylformamide suspension (400 ml) of 2-chloro-6-morpholin-4-yl-9H-purine (32.4 g; purity, approx. 96%; 130.2 mmol) at room temperature and the resulting mixture was stirred at 80 C. for 3 hours in a nitrogen atmosphere. The reaction mixture was left standing to cool, then poured into ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate solution, and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure and the resulting solid was washed with diethyl ether and collected by filtration to give the title compound (26.9 g, 70%) as a colorless acicular crystal. The mother liquor was further concentrated by the same procedure to give the secondary crystal of the title compound (7.68 g, 20%) as a white solid.1H-NMR (CDCl3) δ: 0.41-0.46 (2H, m), 0.64-0.69 (2H, m), 1.26-1.35 (1H, m), 3.81-3.85 (4H, m), 4.00 (2H, d, J=6.87 Hz), 4.05-4.55 (4H, brm), 7.81 (1H, s).
  • 15
  • [ 6165-68-0 ]
  • [ 4010-81-5 ]
  • [ 1062203-73-9 ]
  • 16
  • [ 4010-81-5 ]
  • [ 6165-69-1 ]
  • [ 1062203-77-3 ]
  • 17
  • [ 4010-81-5 ]
  • [ 55552-70-0 ]
  • [ 1062204-15-2 ]
  • 18
  • [ 4010-81-5 ]
  • [ 59016-93-2 ]
  • [ 1062203-86-4 ]
  • 19
  • [ 4010-81-5 ]
  • [ 89466-08-0 ]
  • [ 1062203-80-8 ]
  • 20
  • [ 4010-81-5 ]
  • [ 71597-85-8 ]
  • [ 1062203-83-1 ]
  • 21
  • [ 4010-81-5 ]
  • [ 94839-07-3 ]
  • [ 1062203-92-2 ]
  • 22
  • [ 4010-81-5 ]
  • [ 150255-96-2 ]
  • [ 1062204-03-8 ]
  • 23
  • [ 4010-81-5 ]
  • [ 147621-18-9 ]
  • [ 1208243-81-5 ]
  • 24
  • [ 4010-81-5 ]
  • 2.3-dihydro-1,4-benzodioxin-6-ylboronic acid [ No CAS ]
  • [ 1062204-13-0 ]
  • 25
  • [ 4010-81-5 ]
  • 3-(methylsulfonamido)phenylboronic acid [ No CAS ]
  • [ 1062204-08-3 ]
  • 26
  • [ 4010-81-5 ]
  • [ 373384-18-0 ]
  • [ 1062204-17-4 ]
  • 27
  • [ 4010-81-5 ]
  • [ 149104-88-1 ]
  • [ 1062204-20-9 ]
  • 28
  • [ 4010-81-5 ]
  • [ 123088-59-5 ]
  • [ 1208243-80-4 ]
  • 29
  • [ 4010-81-5 ]
  • [ 1208308-11-5 ]
  • [ 1062204-60-7 ]
  • 30
  • [ 4010-81-5 ]
  • [ 109384-19-2 ]
  • [ 1062204-82-3 ]
  • 31
  • [ 4010-81-5 ]
  • [ 78-77-3 ]
  • [ 1198171-89-9 ]
YieldReaction ConditionsOperation in experiment
100% With potassium carbonate; In N,N-dimethyl-formamide; at 80℃; for 5h; N,N-Dimethylformamide (60 ml), isobutyl bromide (2 ml, 18 mmol), and potassium carbonate (3 g) were added to 2-chloro-6-morpholin-4-yl-9H-purine (5 g, 17 mmol) and the resulting mixture was stirred at 80 C. for 5 hours. The reaction mixture was cooled and partitioned with ethyl acetate and water and the organic layer was dried over magnesium sulfate. The solvent was evaporated under reduced pressure to give the title compound (5.2 g, 100%) as a pale yellow oil.1H-NMR (CDCl3) δ: 0.94 (6H, d, J=6.30 Hz), 2.20-2.29 (1H, m), 3.82-3.84 (4H, m), 3.96 (2H, d, J=7.45 Hz), 4.30 (4H, brs), 7.66 (1H, s).
  • 32
  • [ 4010-81-5 ]
  • [ 74-88-4 ]
  • [ 1148003-35-3 ]
YieldReaction ConditionsOperation in experiment
95% With caesium carbonate; In acetonitrile; at 20℃; To a suspension of <strong>[4010-81-5]4-(2-chloro-9H-purin-6-yl)morpholine</strong> (S29.1) (1.00 g, 4.18 mmol) and CS2CO3 (2.72 g, 8.25 mmol) in ACN (30 mL) was added iodomethane (0.89 g, 0.39 mL). The reaction mixture was stirred at r.t o.n. The reaction mixture was diluted with DCM, washed with water (xl), dried over MgSO4 and concentrated in vacuo. The crude solid was then tritu- rated with diethyl ether to give the title compound as a white powder (1.01 g, 95%). 1H NMR (401 MHz, Chloroform-d) δ 7.67 (s, 1H), 4.29 (br s, 4H), 3.86 - 3.80 (m, 4H), 3.78 (s, 3H). LCMS: (Method C) Rf = 2.554 min, (ESI) m/z: 254.1 ([M+H]+, 100%).
91% With caesium carbonate; In acetonitrile; at 20℃; for 4h; Cs2CO3 (24.437g, 75mmol) and MeI (4.7mL, 75mmol) was slowly added to the acetonitrile solution of 4-(2-Chloro-9H-purin-6-yl)morpholine (11.965g, 50mmol). The mixture was stirred under room temperature for 4h until the starting materials completely transformed. The solvent was removed under reduced pressure and the residue was suspended in dichloromethane. The suspension was stirred for 1h and separated by filtration. The filtrate was concentrated under reduced pressure to afford the crude product, which was recrystallized by ethyl acetate to afford 4-(2-chloro-9-methyl-9H-purin-6-yl)morpholine (11.633g, 91%) as a white solid. ESI-MS [M+Na]+ (m/z): 276.1.
91% With caesium carbonate; In acetonitrile; at 0 - 20℃; for 4h; Place <strong>[4010-81-5]4-(2-chloro-9H-purin-6-yl)morpholine</strong> (11.950g, 50mmol) in a three-necked flask, add acetonitrile (300mL) and cesium carbonate (75mmol), and cool the reaction solution to 0-5 , slowly add iodomethane (150mmol) dropwise, after dripping, warm up to room temperature and react for 4h, distill off the solvent under reduced pressure, then add 500mL dichloromethane to the remaining solid and stir vigorously for 1h, filter with suction, filter cake with dichloromethane ( 50mL) was washed, the filtrate was concentrated under reduced pressure and recrystallized with ethyl acetate, and then dried under vacuum at 45C to obtain the product 49-1 (11.556g, 45.675mmol) with a yield of 91%.
With caesium carbonate; In N,N-dimethyl-formamide; at 50℃; To 4-(2-chloro-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)morpholine (100 g) in methanol (500 mL) at 500C was added p-toluenesulfonic acid monohydrate (6 g). The reaction was stirred for 30 mins, whereupon white solid has crashed fully out of solution. The solid was filtered and collected through Buchner funnel, rinsed with Methanol and dried under vacuum to get <strong>[4010-81-5]4-(2-chloro-9H-purin-6-yl)morpholine</strong>. Cesium carbonate (200 g) and iodomethane (30 mL) were subsequently added to a stirring solution of 4-(2-chloro-9H-purin-6- yl)morpholine in DMF at 500C. The reaction was monitored by lc-ms until complete, about 30 minutes, whereupon the solvent was concentrated to dryness. Subsequent suspension of the crude reaction in water crashed out 4-(2-chloro-9-methyl-9H-purin-6-yl)morpholine (72 g) as a white solid, which was filtered and dried under vacuum overnight.

  • 33
  • [ 95758-04-6 ]
  • [ 4010-81-5 ]
YieldReaction ConditionsOperation in experiment
With toluene-4-sulfonic acid; In methanol; at 50℃; for 0.5h; To 4-(2-chloro-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)morpholine (100 g) in methanol (500 mL) at 500C was added p-toluenesulfonic acid monohydrate (6 g). The reaction was stirred for 30 mins, whereupon white solid has crashed fully out of solution. The solid was filtered and collected through Buchner funnel, rinsed with Methanol and dried under vacuum to get 4-(2-chloro-9H-purin-6-yl)morpholine. Cesium carbonate (200 g) and iodomethane (30 mL) were subsequently added to a stirring solution of 4-(2-chloro-9H-purin-6- yl)morpholine in DMF at 500C. The reaction was monitored by lc-ms until complete, about 30 minutes, whereupon the solvent was concentrated to dryness. Subsequent suspension of the crude reaction in water crashed out 4-(2-chloro-9-methyl-9H-purin-6-yl)morpholine (72 g) as a white solid, which was filtered and dried under vacuum overnight.
  • 35
  • [ 4010-81-5 ]
  • [ 1383810-36-3 ]
  • 36
  • [ 4010-81-5 ]
  • [ 1395172-07-2 ]
  • 37
  • [ 590-92-1 ]
  • [ 4010-81-5 ]
  • [ 141-78-6 ]
  • [ 1382980-99-5 ]
YieldReaction ConditionsOperation in experiment
83% A solution of 4-(2-chloro-9H-purin-6-yl)morpholine (3.0 g, 13 mmol) in DMF (39 mL) was treated with cesium carbonate (8.2 g, 25 mmol) and stirred at ambient temperature for 10 minutes. 3-bromopropanoic acid, ethyl ester (6.8 g, 38 mmol) was introduced and the reaction mixture was heated at 50C for 2 hr. Partial conversion prompted the addition of cesium carbonate (8.2 g, 25 mmol) and 3-bromopropanoic acid, ethyl ester (6.8 g, 38 mmol), and the reaction mixture was heated at 70C. The reaction mixture was cooled to ambient temperature and diluted with brine and DCM and the layers separated. The aqueous phase was extracted into DCM (3x), dried over sodium sulfate, filtered, and absorbed onto celite for purification by flash chromatography to afford ethyl 3-(2-chloro-6-morpholino-9H-purin-9-yl)propanoate as a white solid (3.5 g, 83%). LC/MS (ESI+): m/z 340 (M+H)
  • 38
  • [ 4010-81-5 ]
  • [ 1382980-80-4 ]
  • 39
  • [ 4010-81-5 ]
  • [ 1382980-82-6 ]
  • 40
  • [ 4010-81-5 ]
  • [ 1382979-52-3 ]
  • 41
  • [ 4010-81-5 ]
  • [ 1382980-84-8 ]
  • 42
  • [ 4010-81-5 ]
  • [ 1392421-85-0 ]
  • 43
  • [ 4010-81-5 ]
  • [ 1392421-29-2 ]
  • 44
  • [ 4010-81-5 ]
  • cis-2,6-dimethylmorpholine [ No CAS ]
  • [ 1392421-84-9 ]
YieldReaction ConditionsOperation in experiment
98% In ISOPROPYLAMIDE; at 130℃; for 40h; b) 2-((2S,6 ?)-2,6-Dimethyl-morpholin-4-yl)-6-morpholin-4-yl-9H-purineTo the solution of 2-chloro-6-morpholin-4-yl-9H-purine (1.5 g, 6.26 mmol) in DMA (5 mL) was added cis-2,6 dimethylmorpholine (1 .42 g, 12.52 mmol), followed by DIPEA (2.1 mL, 12.02 mmol). The mixture was stirred at 130 C for 40 hours. Upon completion of the reaction, the solution was poured into water. The aqueous layer was extracted with EtOAc three times. The combined organic layers were dried over Na2S04, filtered and the solvent was removed under reduced pressure to provide 2-((2S,6R)-2,6-dimethyl-morpholin-4-yl)-6-morpholin-4-yl- 9H-purine (1.96 g, 98%) as a yellow solid. LC/MS analysis method 7 ,mass (ES+) m/z 319.2 1HNMR (DMSO-d6): 12.37 (1 H, s), 7.76 (1 H, s), 4.38 (2H, d), 4.12 (4H, brs), 3.69 (4H, m), 3.54 (2H, m), 2.40 (2H, m), 1 .14 (6H, d).
  • 45
  • [ 4010-81-5 ]
  • 2-(2-chloro-6-morpholino-9H-purin-9-yl)ethanamine [ No CAS ]
  • 46
  • [ 4010-81-5 ]
  • (E)-methyl 3-(4-(((2-(2-chloro-6-morpholino-9H-purin-9-yl)ethyl)amino)methyl)phenyl)acrylate [ No CAS ]
  • 47
  • [ 4010-81-5 ]
  • [ 624-75-9 ]
  • 2-(2-chloro-6-morpholino-9H-purin-9-yl)acetonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
95% With potassium carbonate; In dimethyl sulfoxide; acetonitrile; at 60℃; for 3h; Step 2: Synthesis of 2-(2-chloro-6-morpholino-9H-purin-9-yl)acetonitrile (14c)To a solution of 13a (1.18 g, 4.94 mmol) in acetonitrile/DMSO (19:1) was added 2- <strong>[624-75-9]iodoacetonitrile</strong> (0.71 mL, 9.87 mmol) and K2C03 (1.36 g, 9.87 mmol). The resulting mixture was heated at 60CC for 3 h. Then the solvents were removed in vacuo and water was added. The aqueous layer was extracted with DCM (x2) and the combined organic layers was washed with brine (xl), dried over MgSO4 and evaporated in vacuo. The crude oil was purified by flash chromatography(silica, 50% ethyl acetate in hexanes) to afford 14c (1.31 g, 95%) as pale brown solid.
  • 48
  • [ 4010-81-5 ]
  • [ 106-95-6 ]
  • C12H14ClN5O [ No CAS ]
YieldReaction ConditionsOperation in experiment
83% With sodium hydroxide; In water; at 100℃; for 0.166667h;Microwave irradiation; General procedure: To a mixtureof uracil (0.056 g, 0.5 mmol) and NaOH (0.014 g, 0.6 mmol) in neat H2O (2mL), allyl bromide (0.052 mL, 0.6 mmol) was added. Then themixture was put intothe microwave reactor and irradiated at 0-400W(internal temperature: 100C) for10 minutes. After completion of the reaction, the mixture was concentrated underreduced pressure and the residue was purified by column chromatography usingEtOAc-cyclohexane (9:1) as the eluent to afford 3a, yield 82%.
  • 49
  • [ 110-91-8 ]
  • [ 5451-40-1 ]
  • [ 4010-81-5 ]
YieldReaction ConditionsOperation in experiment
99% In methanol; at 0 - 20℃; for 2h; To a suspension of 2,6-dichloropurine (2.00 g, 10.58 mmol) in MeOH was added dropwise morpholine (2.04 g/2.02 mL, 23.42 mmol) at 0 C. The reaction mixture was then stirred at r.t for 2 hr. This thick suspension was cooled to 0 C again and stirred for 15 min. The solid was collected via filtration and washed with MeOH to give the title compound as a white powder (2.51 g, 99%). 1H NMR (401 MHz, DMSO -d6) δ 8.15 (s, 1H), 4.18 (br s, 4H), 3.77 - 3.65 (m, 4H). LCMS: (Method C) Rf = 3.034 min, (ESI) m/z: 240.1 ([M+H]+, 100%).
90% In methanol; at 0 - 20℃; for 2h; Morpholine (150mmol) was added dropwise to the MeOH (500mL) solution of 2,6-dichloropurine (18.900g, 100mmol) at 0 . The mixture was stirred under room temperature for 2h until the starting materials completely transformed. Then the precipitate was collected by filtration, and the filter cake was washed by water (50mL) and MeOH (30mL), dried under reduced pressure to afford 4-(2-Chloro-9H-purin-6-yl)morpholine (21.412g, 90%) as a white solid. ESI-MS [M+Na]+ (m/z): 262.2.
  • 50
  • [ 4010-81-5 ]
  • 1-(2-chloro-6-morpholino-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-8-yl)-N-methylmethanamine [ No CAS ]
  • 51
  • [ 4010-81-5 ]
  • ethyl 2-(((2-chloro-6-morpholino-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxylate [ No CAS ]
  • 52
  • [ 4010-81-5 ]
  • C30H36N8O5 [ No CAS ]
  • 53
  • [ 4010-81-5 ]
  • C29H35N9O4 [ No CAS ]
  • 54
  • [ 4010-81-5 ]
  • C27H33N11O4 [ No CAS ]
  • 55
  • [ 4010-81-5 ]
  • C29H35N9O5 [ No CAS ]
  • 56
  • [ 4010-81-5 ]
  • C25H28N8O4 [ No CAS ]
  • 57
  • [ 4010-81-5 ]
  • C24H27N9O3 [ No CAS ]
  • 58
  • [ 4010-81-5 ]
  • 1-((2-chlorine-9-methyl-6-morpholine-9H-purine-8-yl)-N-methyl)methylamine [ No CAS ]
  • 59
  • [ 4010-81-5 ]
  • C22H25N11O3 [ No CAS ]
  • 60
  • [ 4010-81-5 ]
  • C24H27N9O4 [ No CAS ]
  • 61
  • [ 4010-81-5 ]
  • C27H32N8O4 [ No CAS ]
  • 62
  • [ 4010-81-5 ]
  • C28H34N8O4 [ No CAS ]
  • 63
  • [ 4010-81-5 ]
  • C30H36N8O4 [ No CAS ]
  • 64
  • [ 4010-81-5 ]
  • C26H31N9O3 [ No CAS ]
  • 65
  • [ 4010-81-5 ]
  • C27H33N9O3 [ No CAS ]
  • 66
  • [ 4010-81-5 ]
  • C29H35N9O3 [ No CAS ]
  • 67
  • [ 4010-81-5 ]
  • C24H29N11O3 [ No CAS ]
  • 68
  • [ 4010-81-5 ]
  • C25H31N11O3 [ No CAS ]
  • 69
  • [ 4010-81-5 ]
  • C27H33N11O3 [ No CAS ]
  • 70
  • [ 4010-81-5 ]
  • C26H31N9O4 [ No CAS ]
  • 71
  • [ 4010-81-5 ]
  • C27H33N9O4 [ No CAS ]
  • 72
  • [ 4010-81-5 ]
  • C29H35N9O4 [ No CAS ]
  • 73
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((9-ethyl-2-(4-methoxyphenyl)-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 74
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((9-isopropyl-2-(4-methoxyphenyl)-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 75
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((9-cyclopentyl-2-(4-methoxyphenyl)-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 76
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((2-(4-aminophenyl)-9-ethyl-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 77
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((2-(4-aminophenyl)-9-isopropyl-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 78
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((2-(4-aminophenyl)-9-cyclopentyl-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 79
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((2-(2-aminopyrimidin-5-yl)-9-ethyl-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 80
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((2-(2-aminopyrimidin-5-yl)-9-isopropyl-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 81
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((2-(2-aminopyrimidin-5-yl)-9-cyclopentyl-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 82
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((9-ethyl-2-(6-methoxypyridin-3-yl)-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 83
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((9-isopropyl-2-(6-methoxypyridin-3-yl)-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 84
  • [ 4010-81-5 ]
  • N-hydroxy-2-(((9-cyclopentyl-2-(6-methoxypyridin-3-yl)-6-morpholino-9H-purin-8-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide [ No CAS ]
  • 85
  • [ 4010-81-5 ]
  • C12H15ClN6O [ No CAS ]
  • 86
  • [ 4010-81-5 ]
  • 2-(((2-chlorine-9-methyl-6-morpholine-9H-purine-8-yl))methyl(methyl)amino)pyrimidine-5-carboxylic acid ethyl ester [ No CAS ]
  • 87
  • [ 4010-81-5 ]
  • C25H28N8O4 [ No CAS ]
  • 88
  • [ 4010-81-5 ]
  • C26H30N8O4 [ No CAS ]
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4010-81-5 ]

Chlorides

Chemical Structure| 1148003-35-3

[ 1148003-35-3 ]

4-(2-Chloro-9-methyl-9H-purin-6-yl)morpholine

Similarity: 0.88

Chemical Structure| 114684-96-7

[ 114684-96-7 ]

4-(2-Chloro-5H-pyrrolo[3,2-d]pyrimidin-4-yl)morpholine

Similarity: 0.85

Chemical Structure| 53840-89-4

[ 53840-89-4 ]

4-(2-Chloropyrido[3,2-d]pyrimidin-4-yl)morpholine

Similarity: 0.85

Chemical Structure| 149246-43-5

[ 149246-43-5 ]

7,13-Bis(8-chloro-7-methyl-7H-purin-6-yl)-1,4,10-trioxa-7,13-diazacyclopentadecane

Similarity: 0.84

Chemical Structure| 1225161-95-4

[ 1225161-95-4 ]

2-((2-Chloro-9H-purin-6-yl)amino)acetic acid

Similarity: 0.81

Related Parent Nucleus of
[ 4010-81-5 ]

Morpholines

Chemical Structure| 1148003-35-3

[ 1148003-35-3 ]

4-(2-Chloro-9-methyl-9H-purin-6-yl)morpholine

Similarity: 0.88

Chemical Structure| 2846-96-0

[ 2846-96-0 ]

4-(1H-Purin-6-yl)morpholine

Similarity: 0.88

Chemical Structure| 114684-96-7

[ 114684-96-7 ]

4-(2-Chloro-5H-pyrrolo[3,2-d]pyrimidin-4-yl)morpholine

Similarity: 0.85

Chemical Structure| 53840-89-4

[ 53840-89-4 ]

4-(2-Chloropyrido[3,2-d]pyrimidin-4-yl)morpholine

Similarity: 0.85

Chemical Structure| 18202-52-3

[ 18202-52-3 ]

6-Morpholino-9H-purin-2-amine

Similarity: 0.84

Purines

Chemical Structure| 1148003-35-3

[ 1148003-35-3 ]

4-(2-Chloro-9-methyl-9H-purin-6-yl)morpholine

Similarity: 0.88

Chemical Structure| 2846-96-0

[ 2846-96-0 ]

4-(1H-Purin-6-yl)morpholine

Similarity: 0.88

Chemical Structure| 18202-52-3

[ 18202-52-3 ]

6-Morpholino-9H-purin-2-amine

Similarity: 0.84

Chemical Structure| 149246-43-5

[ 149246-43-5 ]

7,13-Bis(8-chloro-7-methyl-7H-purin-6-yl)-1,4,10-trioxa-7,13-diazacyclopentadecane

Similarity: 0.84

Chemical Structure| 1225161-95-4

[ 1225161-95-4 ]

2-((2-Chloro-9H-purin-6-yl)amino)acetic acid

Similarity: 0.81